Editorial: Which patients with suspected myocardial ischemia and left bundle-branch block should receive thrombolytic agents?

Annals of Emergency Medicine

Volumn 37, Issue 5, 2001, Pages 439-444

  Gallagher, E John ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; AGE; CLINICAL TRIAL; EDITORIAL; ELECTROCARDIOGRAM; FIBRINOLYTIC THERAPY; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE ISCHEMIA; HUMAN; MEDICAL DECISION MAKING; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; STROKE; ALGORITHM; CEREBROVASCULAR ACCIDENT; DECISION TREE; ELECTROCARDIOGRAPHY; EMERGENCY TREATMENT; EVIDENCE BASED MEDICINE; HEART BUNDLE BRANCH BLOCK; HEART INFARCTION; METHODOLOGY; MORTALITY; NOTE; PATIENT SELECTION; SENSITIVITY AND SPECIFICITY; STANDARD; SURVIVAL; TIME; TREATMENT OUTCOME;

ALGORITHMS; BUNDLE-BRANCH BLOCK; CEREBROVASCULAR ACCIDENT; DECISION TREES; ELECTROCARDIOGRAPHY; EMERGENCY TREATMENT; EVIDENCE-BASED MEDICINE; FIBRINOLYTIC AGENTS; HUMANS; MYOCARDIAL INFARCTION; PATIENT SELECTION; PRACTICE GUIDELINES; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0035006148     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1067/mem.2001.114761     Document Type: Article

References (24)

1. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
2. Use of reperfusion treatment for acute myocardial infarction in the United States
3. Thrombolytic therapy for eligible elderly patients with acute myocardial infarction
4. Effects of intravenous APSAC on mortality after acute myocardial infarction: Preliminary report of a placebo-controlled clinical trial
5. Comparison of intravenous urokinase plus heparin versus heparin alone in acute myocardial infarction
6. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian Study of Early Thrombolysis (ASSET)
7. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
8. A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM); mortality, morbidity, and infarct size at 21 days
9. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction
10. A randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction: ISIS-3
11. Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction
12. Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction
13. Right bundle branch block as a cause of false-negative ECG classification of inferior myocardial infarction
14. Right bundle branch block-induced Q waves simulating anterior myocardial infarction extension
15. Acute myocardial infarction and left bundle-branch block - Can we lift the veil?
16. Clinical policy: Critical issues in the evaluation and management of adult patients presenting with suspected acute myocardial infarction or unstable angina
17. Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block
18. Can myocardial infarction be rapidly identified in emergency department patients who have left bundle-block branch block
19. Electrocardiographic diagnosis of myocardial infarction in patients with left bundle branch block
20. Application of likelihood ratios to clinical decision rules: Defining the limits of clinical expertise
21. Should the electrocardiogram he used to guide therapy for patients with left bundle-branch block and suspected myocardial infarction?
22. Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction